Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of $103.18B. The enterprise value is $155.61B.

Bristol-Myers Squibb has 2,034,763,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bristol-Myers Squibb’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Bristol-Myers Squibb is -12.81. Bristol-Myers Squibb’s PEG ratio is 0.06.

In the last 12 months, Bristol-Myers Squibb had revenue of 48.30B and earned -8.95B in profits. Earnings per share was -4.41.

In the last 12 months, operating cash flow was 15.19B and capital expenditures -1.25B, giving a free cash flow of 13.94B billion.

Bristol-Myers Squibb pays an annual dividend of $0.62, resulting in a dividend yield of 4.94%

Bristol-Myers Squibb upcoming earnings date is Apr 24, 2025, TBA Not Confirmed.

Bristol-Myers Squibb as a current ratio of 1.25, with Debt / Equity ratio of 313.44%

In the past 12 months, Bristol-Myers Squibb has paid 554.00M in taxes.

Bristol-Myers Squibb EV to EBITDA ratio is 49.08, with an EV/FCF ratio of 11.15.

Bristol-Myers Squibb has $10.86B in cash and marketable securities with $6.29B in debt, giving a net cash position of $40.34B billion.

Gross margin is 66.66%, with operating margin of 0.00%, and net profit margin of -18.53%.

The average price target for Bristol-Myers Squibb is $58.29, which is 11.43% higher than the current price. The consensus rating is Hold